Clinical Trial Update: A Phase IV, Two-part, Open-label Study Assessing the Pharmacokinetics, Safety and Pharmacodynamics of Spironolactone Oral Suspension in Pediatric Patients [Phase 4]

View source ↗

Summary

Phase IV open-label pharmacokinetics and safety study of spironolactone oral suspension in pediatric patients with edema due to heart failure or cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Edema Due to Cirrhosis
• Edema Due to Heart Failure

Drugs mentioned

• spironolactone oral suspension (spironolactone)

Snippet

Sponsor: CMP Development, LLC | Conditions: Edema Due to Heart Failure or Cirrhosis | Phase 4 | Status: UNKNOWN